Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLOVER BIO-B

0.480
+0.12535.21%
Volume:35.86M
Turnover:16.12M
Market Cap:622.56M
PE:-0.61
High:0.490
Open:0.365
Low:0.365
Close:0.355
Loading ...

Company Profile

Company Name:
CLOVER BIO-B
Exchange:
SEHK
Establishment Date:
2007
Employees:
300
Office Location:
No. 758 West Nanjing Road,Room 1901,Jing'an District,Shanghai,China
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Clover Biopharmaceuticals Ltd is a China-based company mainly engaged in pharmaceutical business. The Company's main business is the development of new vaccines and biotherapeutic candidates for infectious diseases, cancer and autoimmune diseases. The Company's products are mainly used to treat the new coronavirus, malignant ascites, and ankylosing spondylitis.

Directors

Name
Position
LIANG Peng
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
Liang Joshua G
Executive Director
Xiaobin Wu
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
LIAO Xiang
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Jeffrey Farrow
Independent Director,Audit Committee Member
Thomas LEGGETT
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
Xiaodong Wang
Director,Member of the Remuneration and Assessment Committee
Donna Marie Ambrosino
Director,Member of the Nomination Committee

Shareholders

Name
Position
Liang Joshua G
CEO
ZHOU Qing Ling
Corporate Secretary
WANG Xiao Yan
Corporate Secretary
LIANG Peng
Chief Science Officer
NI Qi Rui
Other Senior Executives
CAI Long He
Other Senior Executives